Frequency of Red Blood Cell Alloimmunization in Patients with Sickle Cell Disease in Palestine
Open Access
- 6 June 2018
- journal article
- research article
- Published by Wiley in Advances in Hematology
- Vol. 2018, 1-7
Abstract
Background. Transfusion of red blood cells (RBC) is an essential therapeutic tool in sickle cell disease (SCD). Repeated RBC transfusions can cause alloimmunization which causes difficulty in cross-matching and finding compatible blood for transfusions. This study aimed to investigate the frequency of RBC alloimmunization and related risk factors among Palestinian SCD patients.Materials and Methods. A multicenter cross-sectional study on 116 previously transfused SCD patients from three centers in West Bank, Palestine. Demographic, medical data and history of transfusion were recorded. Blood samples were collected from transfused consenting SCD patients. Gel card method was used for antibody screening and identification. In all patients, autocontrol and direct antiglobulin (DAT) test were performed using polyspecific (anti-IgG + C3d) anti-human globulin (AHG) gel cards for the detection of autoantibodies.Results. Of the SCD patients, 62 (53.4%) patients were HbSS and 54 (46.6%) patients were sickleβ-thalassemia (S/β-thal). There were 53 (45.7%) females and 63 (54.3%) males. Mean age was 18.8 years (range 3-53 years). The frequency of RBC alloimmunization among SCD patients was 7.76%, with anti-K showing the highest frequency (33.3%) followed by anti-E (22.2%), anti-D (11.1%), anti-C (11.1%), and anti-c (11.1%). All reported IgG alloantibodies were directed against antigens in the Rh (66.7%) and Kell (33.3%) systems. Older ages of patients, increased number of blood units transfused, and splenectomy were the commonest risk factors for alloimmunization in our study.Conclusions. RBC alloimmunization rate among Palestinian SCD patients is low compared to neighboring countries and countries all over the world but still warrants more attention. Phenotyping of donors/recipients’ RBC for Rh antigens and K1(partial phenotype matching) before their first transfusion may reduce the incidence of alloimmunization.Keywords
This publication has 39 references indexed in Scilit:
- Red blood cell alloimmunization in sickle cell disease patients in UgandaTransfusion, 2009
- Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusionTransfusion, 2009
- Red blood cell alloantibodies after transfusion: factors influencing incidence and specificityTransfusion, 2005
- Spectrum of β-Globin Gene Mutations Among Thalassemia Patients in the West Bank Region of PalestineHemoglobin, 2005
- Risk factors for alloimmunization by patients with sickle cell diseaseBrazilian Journal of Medical and Biological Research, 2005
- Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United KingdomBritish Journal of Haematology, 2001
- Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD‐specific exonsTransfusion, 1998
- Alloimmunization in Sickle Cell Anemia and Transfusion of Racially Unmatched BloodNew England Journal of Medicine, 1990
- Rapid and non‐radioactive prenatal diagnosis of β thalassaemia and sickle cell disease: application of the polymerase chain reaction (PCR)British Journal of Haematology, 1988
- The incidence of development of irregular red cell antibodies in patients with sickle cell anemiaTransfusion, 1986